Form 8-K - Current report:
SEC Accession No. 0001193125-25-051461
Filing Date
2025-03-11
Accepted
2025-03-11 08:05:15
Documents
15
Period of Report
2025-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d916063d8k.htm   iXBRL 8-K 29901
2 EX-99.1 d916063dex991.htm EX-99.1 11558
6 GRAPHIC g916063g0311060721179.jpg GRAPHIC 3394
  Complete submission text file 0001193125-25-051461.txt   178559

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20250309.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20250309_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20250309_pre.xml EX-101.PRE 11724
17 EXTRACTED XBRL INSTANCE DOCUMENT d916063d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 25725902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)